Looks like we aren't getting a psoriasis indication at the 5mg dose(failed to meet endpoint) and the toxicity of the 10mg killed it off in Europe and has not been approved for us. http://www.pfizer.com/news/press-release/press-release-detail/pfizer_announces_detailed_results_of_opt_compare_phase_3_study_of_tofacitinib_5_mg_and_10_mg_twice_daily_compared_to_high_dose_enbrel_in_adults_with_moderate_to_severe_chronic_plaque_psoriasis